Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

MorphoSys AG

MOR•NASDAQ
Healthcare
Biotechnology
$18.96
$0.45(2.43%)
U.S. Market is Open • 12:27

MorphoSys AG (MOR) Stock Overview

Explore MorphoSys AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.9B
P/E Ratio-11.64
EPS (TTM)$-1.50
ROE-1.84%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$46.46

MOR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of MorphoSys AG (MOR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $46.46.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -11.64 and a market capitalization of 2.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
2.43%
3-Month Change
3.10%
6-Month Change
7.12%
Year-to-Date (YTD) Change
96.68%
1-Year Change
155.53%
3-Year Change
26.40%
5-Year Change
-34.39%
All-Time (Max) Change
-27.94%

Contact Information

https://www.morphosys.com
49 89 89927 0
Semmelweisstrasse 7, Planegg, NaN, 82152

Company Facts

4,640 Employees
IPO DateApr 19, 2018
CountryDE

Frequently Asked Questions